Skip to content

RNTX RNTX Total Liabilities & Equity

Total Liabilities & Equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Gilead Sciences logo
Gilead SciencesGILD
$56.28B-0.3%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
CTO
Citius Oncology, Inc.CTOR
$100.7M+10.1%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$79.65M-18.1%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$162.02M+24.8%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's total liabilities & equity?
RNTX (RNTX) reported total liabilities & equity of $26.29M in Q1 2026.
How has RNTX's total liabilities & equity changed year-over-year?
RNTX's total liabilities & equity decreased by 54.4% year-over-year, from $57.63M to $26.29M.
What is the long-term trend for RNTX's total liabilities & equity?
Over 5 years (2020 to 2025), RNTX's total liabilities & equity has grown at a 8.1% compound annual growth rate (CAGR), from $16.34M to $24.16M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.